Paper II
2022 February (2019 Scheme) · 100 marks · 180 min

Question

Pharmacotherapy of Inflammatory Bowel Disease

Q84 marksShort Answers

Answer

  • 5-Aminosalicylates (Sulfasalazine, Mesalamine) — reduce mucosal inflammation locally in the colon; first-line for mild-moderate ulcerative colitis.
  • Corticosteroids (Prednisolone, Budesonide) — induce remission in moderate-severe flares, not used for long-term maintenance given systemic adverse-effect burden.
  • Immunosuppressants (Azathioprine, 6-Mercaptopurine) — steroid-sparing maintenance therapy for patients requiring repeated corticosteroid courses.
  • Biologic agents (Infliximab, Adalimumab — anti-TNF-alpha) — for moderate-severe disease refractory to conventional therapy.

Treatment is generally stepped up from 5-ASA agents through corticosteroids to immunosuppressants/biologics based on disease severity and response, aiming to induce and then maintain remission.

Other Years Asked


Revise MBBS
Preview